Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
PR Newswire (May 13, 2013)
-
PR Newswire (May 9, 2013)
-
-
PR Newswire (Apr 26, 2013)
-
PR Newswire (Mar 15, 2013)
-
PR Newswire (Feb 28, 2013)
-
PR Newswire (Feb 27, 2013)
-
-
PR Newswire (Feb 7, 2013)
-
PR Newswire (Feb 1, 2013)
-
-
PR Newswire (Jan 7, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
Optimer Pharmaceuticals' Encouraging FDA NewsZacks Investment Research • Tue, Jul 5, 2011 -
-
-
-
-
-
Promising Year Ahead for Optimer PharmaZacks Investment Research • Mon, Jun 29, 2009
-
-
-
-
-
-
-
-
-
-
-
-
-
Fund Holdings For 3 Healthcare Stocks, And 4 Other SellsGuruFundPicks • Mon, Jun 18, 2012
-
-
-
-
-
9 Rallying Biotech Stocks Being Snapped Up By Hedge FundsKapitall • Tue, May 15, 2012
-
-
5 Hedge Fund Biotech Stock Picks With Significant Short CoveringKapitall • Tue, Apr 24, 2012
-
-
Optimer Pharmaceuticals, Inc. Q4 2008 Earnings Call TranscriptWed, Mar 11, 2009
-
Optimer Pharmaceuticals, Inc. Q4 2007 Earnings Call TranscriptSun, Apr 27, 2008
-
PR Newswire (May 13, 2013)
-
PR Newswire (May 9, 2013)
-
PR Newswire (Apr 26, 2013)
-
PR Newswire (Mar 15, 2013)
-
PR Newswire (Feb 28, 2013)
-
PR Newswire (Feb 27, 2013)
-
PR Newswire (Feb 7, 2013)
-
PR Newswire (Feb 1, 2013)
-
PR Newswire (Jan 7, 2013)
-
PR Newswire (Dec 24, 2012)
-
PR Newswire (Dec 20, 2012)
-
PR Newswire (Dec 5, 2012)
-
PR Newswire (Nov 7, 2012)
-
PR Newswire (Nov 1, 2012)
OPTR vs. ETF Alternatives
Company Description
Currently, there's no company description for OPTR.
